Global CRISPR and Cas Genes Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2027
"Global CRISPR and Cas Genes Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2027” is a recent report generated by MarketResearch.biz, which offers in-depth insights, revenue details, and other vital information regarding the global CRISPR and cas genes market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global CRISPR and cas genes market report have been segmented on the product, application, end user, and region.
CRISPR and Cas is a unique technology that enables researchers to edit parts of the genome by either removing, adding or altering sections of the DNA sequence. CRISPR refers to clustered regularly interspaced short palindromic repeats occurring in the genome of certain bacteria. It is faster and more accurate than traditional techniques of editing DNA and furthermore has a wide range of potential applications.
Increasing government and private finding for development of novel therapies is in turn expected to boost growth of global CRISPR and cas genes market over the forecast period. In addition, increasing focus on development of novel therapeutics, owing to growing prevalence of various genetic disorders and cancer is major factor expected to drive growth of global CRISPR and cas genes market over the forecast period. Technological advancements in CRISPR is expected to boost growth of the target market over the forecast period.
However, high costs associated with use of CRISPR is major factor expected to limit growth of the global market, to certain extent. In addition, ethical concerns with regards to human genome editing is expected to hamper growth of the global CRISPR and cas genes market over the forecast period.
Based on end user, the global CRISPR and cas genes market is segmented based on biotechnology & pharmaceutical companies, academic & government research institutes, and contract research organizations. The biotechnology & pharmaceutical companies segment is estimated to account for highest revenue share in 2017.
Market in North America accounted for significant revenue share of the global CRISPR and cas genes market in terms of revenue contribution as compared to that of markets in other regions, in 2017. High adoption of advance technologies coupled with presence of major players in market are factors expected to boost growth of North America CRISPR and cas genes market. Europe accounts for second-highest revenue share contribution to the global market, registering a revenue share of XX.X%, followed by markets in the Asia Pacific, Latin America, and the Middle East & Africa respectively.
In addition, the market in the Asia Pacific is projected to register highest growth in terms of revenue over the next 10 years. Increasing prevalence of various genetic diseases coupled with increasing government investments in R&D, for development of novel therapeutics are another majors factor expected to boost growth of the market in the region over the forecast period.
The Middle East & Africa market is expected to register a CAGR of XX.X% during the forecast period. The market in Latin America is expected to register moderate growth in the global CRISPR and cas genes market over the forecast period.
Segmentation on the basis of product:
- Vector-based Cas
- DNA-free Cas
Segmentation on the basis of application:
- Genome Engineering
- Disease Models
- Functional Genomics
Segmentation on the basis of end user:
- Biotechnology & Pharmaceutical Companies
- Academic & Government Research Institutes
- Contract Research Organizations
Segmentation on the basis of region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2017 Estimated Year 2018 Forecast Period 2018–2028 Revenue in US$
- Addgene, Inc.
- AstraZeneca Plc.
- Bio-Rad Laboratories, Inc.
- Caribou Biosciences, Inc.
- Cellectis S.A.
- Cibus Global, Ltd.
- CRISPR Therapeutics AG
- Editas Medicine, Inc.
- eGenesis Bio
- GE Healthcare
- GenScript Corporation
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!